Conversion from Mycophenolate Mofetil to Enteric-coated Mycophenolate Sodium (myfortic®) in Patients with Gastrointestinal Side Effects: Case Studies

被引：0

作者：

Anita Boswell

Magdi Shehata

机构：

[1] Nottingham University Hospitals,Kidney Transplant Unit

来源：

Drugs | 2006年 / 66卷 / Suppl 2期

关键词：

Prednisolone; Mycophenolate Mofetil; Continuous Ambulatory Peritoneal Dialysis; Mycophenolic Acid; Gastrointestinal Symptom Rate Scale;

D O I：

10.2165/00003495-200666002-00006

中图分类号：

学科分类号：

摘要：

引用

页码：19 / 22

页数：3

共 50 条

[1] Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®) in patients with gastrointestinal side effects:: Case studies
Boswell, Anita
Shehata, Magdi
[J]. DRUGS, 2006, 66 : 19 - 22
[2] Successful conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (Myfortic®) in liver transplant patients with gastrointestinal side effects
Robaeys, G.
Cassiman, D.
Verslype, C.
Monbaliu, D.
Aerts, R.
Pirenne, J.
Nevens, F.
[J]. JOURNAL OF HEPATOLOGY, 2008, 48 : S94 - S94
[3] Successful Conversion From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium (Myfortic) in Liver Transplant Patients With Gastrointestinal Side Effects
Robaeys, G.
Cassiman, D.
Verslype, C.
Monbaliu, D.
Aerts, R.
Pirenne, J.
Nevens, F.
[J]. TRANSPLANTATION PROCEEDINGS, 2009, 41 (02) : 610 - 613
[4] Resolution of gastrointestinal side effects in a patient converted from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®)
Tuncer, Murat
[J]. DRUGS, 2006, 66 : 9 - 10
[5] Resolution of gastrointestinal side effects in a patient converted from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®)
Tuncer M.
[J]. Drugs, 2006, 66 (Suppl 2) : 9 - 10
[6] Improvement in social functioning in kidney transplant patients after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®):: Three case studies
Shah, Tariq
[J]. DRUGS, 2006, 66 : 15 - 17
[7] Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®) resolves gastrointestinal disorders in a patient with severe idiopathic aplastic anaemia
Rohrlich, Pierre-Sinion
Deconinck, Eric
Cahn, Jean-Yves
Plouvier, Emmanuel
[J]. DRUGS, 2006, 66 : 33 - 35
[8] Renal transplant patients with gastrointestinal intolerability to mycophenolate mofetil: Conversion to enteric-coated mycophenolate sodium
Calvo, N.
Sanchez-Fructuoso, A. I.
Conesa, J.
Moreno, A.
Barrientos, A.
[J]. TRANSPLANTATION PROCEEDINGS, 2006, 38 (08) : 2396 - 2397
[9] Improvement in Social Functioning in Kidney Transplant Patients after Conversion from Mycophenolate Mofetil to Enteric-coated Mycophenolate Sodium (myfortic®): Three Case Studies
Tariq Shah
[J]. Drugs, 2006, 66 (Suppl 2) : 15 - 17
[10] Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®) resolves gastrointestinal disorders in a patient with severe idiopathic aplastic anaemia
Rohrlich P.-S.
Deconinck E.
Cahn J.-Y.
Plouvier E.
[J]. Drugs, 2006, 66 (Suppl 2) : 33 - 35

← 1 2 3 4 5 →